Published in Lancet on August 19, 1978
Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol (2007) 1.49
McIndoe lecture, 1978. Burns: McIndoe's contribution and subsequent advances. Ann R Coll Surg Engl (1979) 1.42
Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa. Infect Immun (1994) 1.06
Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats. Infect Immun (1983) 0.93
Measurement of endotoxins with the limulus test in burned patients. J Hyg (Lond) (1979) 0.93
Recent developments for Pseudomonas vaccines. Hum Vaccin (2011) 0.91
Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine. J Hyg (Lond) (1979) 0.82
Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains. Infect Immun (1980) 0.80
New developments in the treatment of gram-negative bacteremia. West J Med (1986) 0.76
The NBT test in burned patients. Br J Exp Pathol (1979) 0.75
Nosocomial pneumonia in patients in intensive care units. West J Med (1985) 0.75
Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet (1969) 8.94
Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin. Br Med J (1967) 3.15
Transfer of anibioic resistanceetween Pseudomonas aeruginosa, Escherichia coli, and other gram-negative bacilli in rns. Lancet (1971) 3.05
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant (2002) 2.69
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med (2001) 2.47
Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa. Br J Exp Pathol (1968) 2.47
Kernel abortion in maize : I. Carbohydrate concentration patterns and Acid invertase activity of maize kernels induced to abort in vitro. Plant Physiol (1986) 2.36
Antiserum and antibiotic in the prophylaxis of burns against Pseudomonas aeruginosa. Br J Plast Surg (1966) 2.21
Inoculum-dependent division lag of Bacillus cultures and its relation to an endogenous factor(s) ("schizokinen"). J Bacteriol (1966) 2.07
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res (1988) 1.99
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood (1994) 1.91
The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. J Gen Microbiol (1983) 1.81
A synchronization effect and its application to stuttering by a portable apparatus. J Appl Behav Anal (1968) 1.74
Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes. Leukemia (2006) 1.74
Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med (1990) 1.72
Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol (1995) 1.71
In Vitro Sugar Transport in Zea mays L. Kernels : I. Characteristics of Sugar Absorption and Metabolism by Developing Maize Endosperm. Plant Physiol (1987) 1.70
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57
Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine. Immunology (1972) 1.56
A new polyvalent Pseudomonas vaccine. J Med Microbiol (1977) 1.51
Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med (1998) 1.51
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol (1994) 1.50
Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant (2008) 1.45
Early protection by vaccines in burns. Br J Exp Pathol (1971) 1.44
Absorbability of beta-sitosterol in humans. Metabolism (1969) 1.44
Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant (2007) 1.41
Successful transfer of DHP-degrading bacteria from Hawaiian goats to Australian ruminants to overcome the toxicity of Leucaena. Aust Vet J (1986) 1.36
Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat Med (1996) 1.35
Tropical legumes of the genus Stylosanthes immobilize and kill cattle ticks. Nature (1982) 1.35
Specificity of early protective responses induced by pseudomonas vaccines. J Hyg (Lond) (1972) 1.31
The role of polymorphonuclear leucocytes in protecting mice vaccinated against Pseudomon as aeruginosa infections. Br J Exp Pathol (1973) 1.31
The invasion of burned skin by Pseudomonas aeruginosa. Br J Dermatol (1973) 1.31
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood (1995) 1.30
Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia. Br J Haematol (2001) 1.29
Controlled trials of a polyvalent pseudomonas vaccine in burns. Lancet (1979) 1.28
Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart Association. Circulation (1987) 1.27
Pancreatic lymphoma. Is surgery mandatory for diagnosis or treatment? Ann Surg (1989) 1.27
Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats. Drug Metab Dispos (1997) 1.26
CT of lymphoma: spectrum of disease. Radiographics (1991) 1.26
Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood (1999) 1.24
BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood (1993) 1.23
Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa. Br J Exp Pathol (1968) 1.21
Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients. Lancet (1980) 1.21
A new Pseudomonas vaccine: preliminary trial on human volunteers. J Hyg (Lond) (1976) 1.21
A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest (2000) 1.20
Geographic differences in vertical connectivity in the Caribbean coral Montastraea cavernosa despite high levels of horizontal connectivity at shallow depths. Mol Ecol (2014) 1.20
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol (2001) 1.20
Passive immunisation against Gram-negative bacilli in burns. Br J Exp Pathol (1970) 1.18
Migraine: a platelet disorder. Lancet (1981) 1.16
Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood (1996) 1.16
Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine. Br J Exp Pathol (1975) 1.14
Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood (1994) 1.14
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia (2010) 1.13
The role of recumbency in the prevention and treatment of postspinal headache. Anesth Analg (1974) 1.13
Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med (2001) 1.10
Passive protection of mice against Pseudomonas aeruginosa by serum from recently vaccinated mice. Br J Exp Pathol (1971) 1.10
Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A (1997) 1.10
Kernel Abortion in Maize : II. Distribution of C among Kernel Carbohydrates. Plant Physiol (1986) 1.10
Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood (1998) 1.09
Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma. Ann Intern Med (1989) 1.08
Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement. Eur J Cancer (1994) 1.06
Standard depth burns in the rat: the importance of the hair growth cycle. Br J Plast Surg (1967) 1.06
Effects of topical chemoprophylaxis on transferable antibiotic resistance in burns. Lancet (1972) 1.05
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia. J Clin Oncol (1994) 1.04
In Vitro Sugar Transport in Zea mays L. Kernels : II. Characteristics of Sugar Absorption and Metabolism by Isolated Developing Embryos. Plant Physiol (1987) 1.03
Intracellular killing of different strains of Pseudomonas aeruginosa by human leucocytes. Br J Exp Pathol (1974) 1.01
Mortality of joggers. JAMA (1982) 1.01
Treatment of acute herpes zoster using ultrasonic therapy. Report on a series of twelve patients. Physiotherapy (1984) 1.00
Growth factor-mediated terminal differentiation of chronic myeloid leukemia. Cancer Res (1994) 1.00
Dynamics of maize endosperm development and DNA endoreduplication. Proc Natl Acad Sci U S A (1995) 1.00
Does ruminal metabolism of mimosine explain the absence of Leucaena toxicity in Hawaii? Aust Vet J (1981) 1.00
Australian goats detoxify the goitrogen 3-hydroxy-4(1H) pyridone (DHP) after rumen infusion from an Indonesian goat. Experientia (1984) 0.98
Detection of ruminal bacteria that degrade toxic dihydroxypyridine compounds produced from mimosine. Appl Environ Microbiol (1990) 0.97
Aryl ester prodrugs of cyclic HPMPC. I: Physicochemical characterization and in vitro biological stability. Pharm Res (1999) 0.95
Detoxification of an immunogenic fraction from a culture filtrate of Pseudomonas aeruginosa. J Hyg (Lond) (1969) 0.93
Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia. J Natl Cancer Inst (1992) 0.93
Measurement of endotoxins with the limulus test in burned patients. J Hyg (Lond) (1979) 0.93
Detection of endotoxins with the Limulus test in burned and unburned mice infected with different species of gram-negative bacteria. J Hyg (Lond) (1975) 0.93
Development of antisense therapeutics. Implications for cancer gene therapy. Ann N Y Acad Sci (1994) 0.93
Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum (1994) 0.93
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen. Bone Marrow Transplant (2008) 0.92
Elimination of alloantibodies by immunoablative high-dose cyclophosphamide. Transplantation (2001) 0.91
Fluorescence in situ hybridization to determine engraftment status after murine bone marrow transplant. Cancer Genet Cytogenet (1992) 0.91
Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant. J Clin Oncol (1996) 0.90
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Ann Oncol (2009) 0.90
Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients. J Clin Oncol (1991) 0.90